España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
MannKind
MNKD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.76
0.1
1.77%
At close: -
$5.80
0.04
0.70%
After Hours: 7:58 PM EDT
Get Report
Comment
Q4 2024 Earnings in 4 days from now on Wed Feb 26th, after the market close
Conference call scheduled in 4 days at 16:30 PM
Click to view the webcast
MannKind (MNKD) Forecast
News
Earnings
MannKind (MNKD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for MannKind (NASDAQ:MNKD) Stock
MannKind Stock (NASDAQ: MNKD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 20, 2024
MannKind shares are trading higher after Well...
Benzinga Newsdesk
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Avi Kapoor
Wells Fargo Initiates Coverage On MannKind wi...
Benzinga Newsdesk
Thursday, December 19, 2024
RBC Capital Upgrades MannKind to Outperform, ...
Benzinga Newsdesk
Monday, December 16, 2024
MannKind Shares Are falling Today: What's Going On?
Vaishali Prayag
MannKind Announced Six-month Results From Its...
Benzinga Newsdesk
Wednesday, December 11, 2024
MannKind, Cipla Report CDSCO In India Has App...
Benzinga Newsdesk
Thursday, November 07, 2024
MannKind Q3 2024 Adj. EPS $0.06 Beats $0.03 E...
Benzinga Newsdesk
Monday, November 04, 2024
MannKind Completes Phase 1 Trial of Inhaled T...
Benzinga Newsdesk
Monday, September 30, 2024
MannKind's Afrezza Demonstrates A1c Control I...
Benzinga Newsdesk
Monday, September 23, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, September 18, 2024
Japan's Pharmaceuticals And Medical Devices A...
Benzinga Newsdesk
Wednesday, August 28, 2024
MannKind shares are trading higher after Oppe...
Benzinga Newsdesk
Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Oppenheimer Maintains Outperform on MannKind,...
Benzinga Newsdesk
Wednesday, August 07, 2024
MannKind Q2 2024 Adj. EPS $0.05 Beats $0.01 E...
Benzinga Newsdesk
Wednesday, July 31, 2024
Mannkind Announced The Launch Of An Education...
Benzinga Newsdesk
Monday, June 24, 2024
Reported Earlier, MannKind's Inhaled Insulin ...
Benzinga Newsdesk
Thursday, June 13, 2024
Rodman & Renshaw Initiates Coverage On MannKi...
Benzinga Newsdesk
Wednesday, May 29, 2024
Pulmatrix Enters Cross License Agreement With...
Benzinga Newsdesk
Thursday, May 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ma...
Benzinga Newsdesk
Wednesday, May 08, 2024
MannKind Q1 2024 Adj EPS $0.05 Beats $0.03 Es...
Benzinga Newsdesk
Monday, May 06, 2024
MannKind Announced The FDA Fast Track Designa...
Benzinga Newsdesk
Tuesday, April 30, 2024
MannKind Will Proceed With Phase 1 Nintedanib...
Benzinga Newsdesk
Monday, April 29, 2024
MannKind shares are trading higher after the ...
Benzinga Newsdesk
MannKind Announces IND Clearance From US FDA ...
Benzinga Newsdesk
Wednesday, April 03, 2024
MannKind Announced That It Has Repaid In Full...
Benzinga Newsdesk
Tuesday, March 26, 2024
MannKind Appoints Christopher Prentiss As CFO...
Benzinga Newsdesk
Friday, March 15, 2024
Cantor Fitzgerald Reiterates Overweight on Ma...
Benzinga Newsdesk
Monday, March 11, 2024
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
Avi Kapoor
What's Going On With MannKind Stock?
Erica Kollmann
MannKind Announced Initial Meal Challenge Dat...
Benzinga Newsdesk
Friday, March 08, 2024
Cramer Says Sprout Social Is In A 'Hot Spot,' But This Energy Stock Is 'Too Down And Out'
Avi Kapoor
Tuesday, March 05, 2024
MannKind Announced That New Clinical Data Fro...
Benzinga Newsdesk
Wednesday, February 28, 2024
Cantor Fitzgerald Reiterates Overweight on Ma...
Benzinga Newsdesk
Tuesday, February 27, 2024
MannKind Q4 2023 Adj EPS $0.02 Beats undefine...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
MannKind Earnings Preview
Benzinga Insights
Thursday, February 15, 2024
MannKind Has Enrolled 305 Patients With Type ...
Benzinga Newsdesk
Thursday, January 04, 2024
HC Wainwright & Co. Reiterates Buy on MannKin...
Benzinga Newsdesk
Tuesday, January 02, 2024
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
MannKind shares are trading higher after the ...
Benzinga Newsdesk
MannKind Sold A 1% Royalty In Net Sales Of Ty...
Benzinga Newsdesk
Wednesday, December 27, 2023
MannKind Entered Into Seventh Amendment To Su...
Benzinga Newsdesk
Wednesday, December 20, 2023
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Tuesday, November 07, 2023
Recap: MannKind Q3 Earnings
Benzinga Insights
MannKind Q3 2023 Adj EPS $0.01 Beats $(0.02) ...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, November 06, 2023
A Preview Of MannKind's Earnings
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
